Stableford Capital II LLC Lowers Stock Holdings in Establishment Labs Holdings Inc. $ESTA

Stableford Capital II LLC cut its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 31.1% during the second quarter, HoldingsChannel.com reports. The fund owned 15,395 shares of the company’s stock after selling 6,964 shares during the quarter. Stableford Capital II LLC’s holdings in Establishment Labs were worth $1,321,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Establishment Labs by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 57,215 shares of the company’s stock valued at $2,335,000 after purchasing an additional 9,557 shares during the period. Geode Capital Management LLC raised its position in Establishment Labs by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock valued at $1,105,000 after purchasing an additional 299 shares in the last quarter. WINTON GROUP Ltd bought a new stake in Establishment Labs during the 2nd quarter valued at $651,000. Nebula Research & Development LLC raised its position in Establishment Labs by 27.9% during the 2nd quarter. Nebula Research & Development LLC now owns 16,214 shares of the company’s stock valued at $692,000 after purchasing an additional 3,538 shares in the last quarter. Finally, Sei Investments Co. lifted its holdings in shares of Establishment Labs by 13.3% in the 2nd quarter. Sei Investments Co. now owns 48,428 shares of the company’s stock worth $2,068,000 after buying an additional 5,668 shares during the period. 72.91% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Establishment Labs news, Director Quiros Juan Jose Chacon sold 105,000 shares of Establishment Labs stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total value of $7,919,100.00. Following the transaction, the director owned 927,504 shares in the company, valued at $69,952,351.68. The trade was a 10.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 9.99% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on ESTA shares. TD Cowen increased their price target on Establishment Labs from $95.00 to $117.00 and gave the stock a “buy” rating in a research report on Monday. Mizuho lifted their price objective on Establishment Labs from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, July 15th. BTIG Research reaffirmed a “buy” rating on shares of Establishment Labs in a research note on Monday, July 13th. Citigroup increased their target price on shares of Establishment Labs from $76.00 to $92.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research report on Wednesday, June 24th. Seven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $93.75.

Establishment Labs Stock Up 0.3%

Shares of NASDAQ ESTA opened at $92.80 on Tuesday. The company has a current ratio of 2.96, a quick ratio of 1.91 and a debt-to-equity ratio of 16.82. The stock has a market capitalization of $2.73 billion, a PE ratio of -62.28 and a beta of 1.07. The stock’s fifty day simple moving average is $85.34 and its two-hundred day simple moving average is $73.77. Establishment Labs Holdings Inc. has a 12-month low of $33.35 and a 12-month high of $97.59.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.10). The company had revenue of $59.88 million during the quarter, compared to the consensus estimate of $57.40 million. Establishment Labs had a negative return on equity of 218.77% and a negative net margin of 19.05%.The company’s revenue was up 44.7% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.70) earnings per share. As a group, analysts expect that Establishment Labs Holdings Inc. will post -1.07 EPS for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.